Supriya Lifescience MD, chairman, board of directors and AGM
NSE: SUPRIYABSE: 543434Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹836.25.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹6,588 Cr733rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 13 Aug 2026
- 33.2
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 27 May 2026
- 5.5
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.12%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 13 Aug 2026
- 18.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 13 Aug 2026
- 21.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 27 May 2026
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 1,62,92342.0% delivered
Supriya Lifescience board of directors
At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
- ChairpersonSatish Waman Wagh
- Managing directorSaloni Satish Wagh
- Managing directorShivani Satish Wagh
- Company Secretary and Compliance OfficerPrachi Suhas Sathe
10 directors5 independent5 executive
- Satish Waman Wagh · ChairpersonExecutive · joined Mar 2008 · reappointed Aug 2024 · 1 listed board · 2 committee seats
- Smita Satish WaghExecutive · joined Mar 2008 · reappointed Jun 2025 · 1 listed board
- Saloni Satish Wagh · Managing directorExecutive · joined Jul 2019 · reappointed Aug 2024 · 1 listed board · 1 committee seat
- Shivani Satish Wagh · Managing directorExecutive · joined Jul 2019 · reappointed Aug 2024 · 1 listed board
- Balasaheb Gulabrao SawantExecutive · joined May 2023 · reappointed May 2026 · 1 listed board
- Neelam Yashpal AroraIndependent · joined Mar 2021 · reappointed Mar 2026 · 63 months as independent · 3 listed boards · 3 as independent · 2 committee seats, 2 as chair
- Ganapati Dadasaheb YadavIndependent · joined Jan 2025 · reappointed Jan 2025 · 17 months as independent · 5 listed boards · 5 as independent · 3 committee seats
- Sunil Subhash BhagwatIndependent · joined Jan 2025 · reappointed Jan 2025 · 17 months as independent · 1 listed board · 1 as independent
- Manish Ishwarlal PanchalIndependent · joined Feb 2026 · reappointed Feb 2026 · 4 months as independent · 2 listed boards · 2 as independent · 7 committee seats, 1 as chair
- Kothandaraman HariIndependent · joined Feb 2026 · reappointed Feb 2026 · 4 months as independent · 2 listed boards · 2 as independent · 2 committee seats, 1 as chair
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
4 directors who left
- Dileep Kumar Jain, left 24 Mar 2026: Tenure Completion
- Dinesh Navnitlal Modi, left 24 Mar 2026: Tenure Completion
- Kedar Shanker Karmarkar, left 1 Feb 2025: Tenure Completion
- Bhairav Manojbhai Chokshi, left 1 Feb 2025: Tenure Completion
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 27 May 202610 of 10 present5 independent · 106 days in between
- 9 Feb 202611 of 12 present7 independent
Audit Committee
Chair Kothandaraman Hari
Ganapati Dadasaheb Yadav, Satish Waman Wagh, Manish Ishwarlal Panchal
- 27 May 20264 of 4 present3 independent · 106 days in between
- 9 Feb 20263 of 3 present2 independent
Nomination and remuneration committee
Chair Kothandaraman Hari
Sunil Subhash Bhagwat, Manish Ishwarlal Panchal
- 27 May 20263 of 3 present3 independent · 106 days in between
- 9 Feb 20263 of 3 present3 independent
Stakeholders Relationship Committee
Chair Manish Ishwarlal Panchal
Satish Waman Wagh, Saloni Satish Wagh
- 27 May 20263 of 3 present1 independent · 106 days in between
- 9 Feb 20263 of 3 present1 independent
Risk Management Committee
Chair Satish Waman Wagh
Saloni Satish Wagh, Ganapati Dadasaheb Yadav
No meeting listed in the filing.
Corporate Social Responsibility Committee
Chair Satish Waman Wagh
Saloni Satish Wagh, Sunil Subhash Bhagwat
- 27 May 20263 of 3 present1 independent · 286 days in between
- 13 Aug 20252 of 3 present1 independent
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Mar 2026.
- Kakaria & Associates LLPPeer-review certificate valid to Mar 2027
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Supriya Lifescience AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Supriya Lifescience dividend history
Annual general meeting, 24 Sep 2026
80,126 shareholders on the register on 4 Sep 2026; present: 6 promoters and 51 others; votes counted by CS Sanam Umbargikar / DSM & Associates.The company's voting result (opens in a new tab)
- To receive, consider, approve and adopt the Audited Financial Statements of the Company for the Financial Year ended March 31, 2026, and the reports of the Board of Directors and Auditors’ thereonOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 2.12%
Turnout: all 72.49% · promoters 100.00% · institutions 34.64% · other public 0.45%
- To declare a Final Dividend of Re. 1.00/- (50%) per Equity Shares of Rs.2/- for the Financial Year ended March 31, 2026.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 2.17%
Turnout: all 72.49% · promoters 100.00% · institutions 34.64% · other public 0.45%
To appoint a Director in place of Dr. Saloni Satish Wagh (DIN: 08491410) who retires by rotation in terms of Section 152 (6) of the Companies Act, 2013, and being eligible, offers herself for re-appointment.MoreLess
Ordinary99.76% for0.24% againstAgainst: promoters 0.00% · institutions 4.13% · other public 2.55%
Turnout: all 72.24% · promoters 99.63% · institutions 34.64% · other public 0.45%
- To ratify the remuneration of Cost Auditors for FY 2025-26OrdinaryPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 3.03%
Turnout: all 72.49% · promoters 100.00% · institutions 34.64% · other public 0.45%
To appoint a Director in place of Ms. Shivani Satish Wagh (DIN:08491420) who retires by rotation in terms of Section 152 (6) of the Companies Act, 2013, and being eligible, offers herself for re-appointment.MoreLess
OrdinaryPromoters have an interest in it100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.13% · other public 2.40%
Turnout: all 68.79% · promoters 99.63% · institutions 5.62% · other public 0.43%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 21 Aug 2026, 1 resolution
79,554 shareholders on the register on 17 Jul 2026; votes counted by CS Sanam Umbargikar / DSM & Associates.The company's voting result (opens in a new tab)
- Re-appointment of Mr. Balasaheb Sawant (DIN: 07743507) as Whole Time Director and Key Managerial Personnel of the Company for a term of three (3) consecutive years from May 26, 2026, to May 25, 2029Special99.69% for0.31% against
Against: promoters 0.00% · institutions 5.62% · other public 1.84%
Turnout: all 72.41% · promoters 100.00% · institutions 33.72% · other public 0.91%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 10 Apr 2026, 3 resolutions
83,037 shareholders on the register on 27 Feb 2026; votes counted by CS Sanam Umbargikar / DSM & Associates.The company's voting result (opens in a new tab)
- Appointment of Mr. Manish Panchal (DIN: 08431492) as Non-Executive Independent Director of the Company for a term of five (5) consecutive years from February 09, 2026, to February 08, 2031.Special99.86% for0.14% against
Against: promoters 0.00% · institutions 2.52% · other public 0.17%
Turnout: all 72.47% · promoters 100.00% · institutions 38.57% · other public 0.34%
- Appointment of Mr. Kothandaraman Hari (DIN: 08901674) as Non-Executive Independent Director of the Company for a term of five (5) consecutive years from February 09, 2026, to February 08, 2031.Special99.86% for0.14% against
Against: promoters 0.00% · institutions 2.52% · other public 0.27%
Turnout: all 72.47% · promoters 100.00% · institutions 38.57% · other public 0.34%
- Re-appointment of Dr. Neelam Arora (DIN: 01603068) as Non-Executive Independent Director of the Company for second term of five (5) consecutive years from March 25, 2026, to March 24, 2031.Special99.86% for0.14% against
Against: promoters 0.00% · institutions 2.52% · other public 0.80%
Turnout: all 72.47% · promoters 100.00% · institutions 38.57% · other public 0.34%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 24 Sep 2025, 5 resolutions
91,607 shareholders on the register on 12 Sep 2025; present: 6 promoters and 43 others; votes counted by CS Sanam Umbargikar / DSM & Associates.The company's voting result (opens in a new tab)
- To receive, consider, approve and adopt the Audited Financial Statements of the Company for the Financial Year ended March 31, 2025 and the reports of the Board of Directors and Auditors’ thereon.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.27%
Turnout: all 73.29% · promoters 100.00% · institutions 44.44% · other public 0.73%
- To declare a Final Dividend of Re. 1.00/- (50%) per Equity Shares of Rs.2/- for the Financial Year ended March 31, 2025Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.29%
Turnout: all 73.29% · promoters 100.00% · institutions 44.44% · other public 0.73%
To appoint a Director in place of Mr. Balasaheb Sawant (DIN: 07743507) who retires by rotation in terms of Section 152 (6) of the Companies Act, 2013, and being eligible, offers himself for re-appointmentMoreLess
Ordinary98.37% for1.63% againstAgainst: promoters 0.00% · institutions 25.40% · other public 0.38%
Turnout: all 73.15% · promoters 100.00% · institutions 43.22% · other public 0.73%
- To ratify the remuneration of Cost Auditors for FY 2025-26Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 1.29%
Turnout: all 73.29% · promoters 100.00% · institutions 44.44% · other public 0.73%
- To appoint M/s DSM & Associates as Secretarial Auditors for a term of 5 consecutive years effective from FY 2025-26 to FY 2029-30Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.41%
Turnout: all 73.29% · promoters 100.00% · institutions 44.44% · other public 0.73%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 23 Apr 2025, 2 resolutions
93,354 shareholders on the register on 21 Mar 2025; votes counted by CS Sanam Umbargikar / DSM & Associates.The company's voting result (opens in a new tab)
- Appointment of Dr. Ganapati Dadasaheb Yadav (DIN: 02235661) as Non Executive Independent Director of the CompanySpecial99.46% for0.54% against
Against: promoters 0.00% · institutions 6.61% · other public 1.13%
Turnout: all 74.42% · promoters 100.00% · institutions 53.30% · other public 0.40%
- 2 - Appointment of Dr. Sunil Subhash Bhagwat (DIN: 10178976) as Non Executive Independent Director of the CompanySpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 1.00%
Turnout: all 74.42% · promoters 100.00% · institutions 53.30% · other public 0.40%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 27 Sep 2024, 6 resolutions
Present: 5 promoters and 43 others.The company's voting result (opens in a new tab)
- To receive, consider, approve and adopt the Audited Financial Statements of the Company for the financial year ended March 31, 2024 and the reports of the Board of Directors and Auditors thereon.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.31%
Turnout: all 75.94% · promoters 99.41% · institutions 69.62% · other public 0.65%
- To declare a Final Dividend on Equity Shares for the Financial Year ended March 31, 2024Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.36%
Turnout: all 75.95% · promoters 99.41% · institutions 69.70% · other public 0.63%
- To appoint a Director in place of Mrs. Smita Satish Wagh (DIN: 00833912) who retires by rotation and, being eligible, offers herself for re-appointment.Ordinary99.94% for0.06% against
Against: promoters 0.00% · institutions 0.53% · other public 0.94%
Turnout: all 75.95% · promoters 99.41% · institutions 69.70% · other public 0.65%
- To ratify the remuneration of Cost Auditors for the FY 2024-25Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.78%
Turnout: all 75.95% · promoters 99.41% · institutions 69.70% · other public 0.65%
- To reappoint Mrs. Smita Satish Wagh (DIN: 00833912) as Whole Time Director & Key Managerial Personnel of the CompanySpecial99.71% for0.29% against
Against: promoters 0.00% · institutions 2.80% · other public 1.13%
Turnout: all 75.95% · promoters 99.41% · institutions 69.70% · other public 0.65%
- To approve continuation of directorship of Mr. Dinesh Navnitlal Modi (DIN: 00004556) as a Non-Executive Independent Director beyond the age of 75 Years.Special99.61% for0.39% against
Against: promoters 0.00% · institutions 3.66% · other public 5.77%
Turnout: all 75.95% · promoters 99.41% · institutions 69.70% · other public 0.65%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 28 Jul 2024, 3 resolutions
The company's voting result (opens in a new tab)
- Change in designation and appointment of Dr. Satish Waman Wagh (DIN: 01456982) as Whole Time Director and Key Managerial Personnel designated as Executive Chairman of the Company.Special96.45% for3.55% against
Against: promoters 0.00% · institutions 43.02% · other public 4.22%
Turnout: all 74.63% · promoters 100.00% · institutions 59.21% · other public 0.88%
- Change in designation and appointment of Dr. Saloni Satish Wagh (DIN: 08491410) as a Managing Director and Key Managerial Personnel of the Company.Special96.52% for3.48% against
Against: promoters 0.00% · institutions 42.10% · other public 4.45%
Turnout: all 74.63% · promoters 100.00% · institutions 59.21% · other public 0.87%
- Change in designation and appointment of Ms. Shivani Satish Wagh (DIN: 08491420) as a Joint Managing Director and Key Managerial Personnel of the Company.Special96.52% for3.48% against
Against: promoters 0.00% · institutions 42.10% · other public 5.39%
Turnout: all 74.63% · promoters 100.00% · institutions 59.21% · other public 0.88%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 29 Sep 2023, 4 resolutions
Present: 5 promoters and 40 others.The company's voting result (opens in a new tab)
- To receive, consider, approve and adopt the Audited Financial Statements of the Company for the financial year ended March 31, 2023 and the reports of the Board of Directors and Auditors thereon.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 2.24%
Turnout: all 73.54% · promoters 99.73% · institutions 42.77% · other public 0.33%
- To declare a Final Dividend on Equity Shares for the Financial Year ended March 31, 2023.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 2.22%
Turnout: all 73.54% · promoters 99.73% · institutions 42.77% · other public 0.33%
- To appoint a Director in place of Ms. Shivani Satish Wagh (DIN: 08491420) who retires by rotation and, being eligible, offers herself for re-appointment.OrdinaryPromoters have an interest in it95.57% for4.43% against
Against: promoters 0.00% · institutions 4.45% · other public 2.71%
Turnout: all 5.42% · promoters 0.00% · institutions 42.77% · other public 0.33%
- To ratify the remuneration of Cost Auditors for the FY 2023-24Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 2.87%
Turnout: all 73.49% · promoters 99.73% · institutions 42.41% · other public 0.33%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
How mutual funds voted
Fund houses must disclose how they vote at every meeting of a company they hold.Funds that hold it
Mutual fund votes, meeting of 24 Sep 2026, 3 fund houses so far (houses' deadline to file 15 Oct 2026)
- To receive, consider, approve and adopt the Audited Financial Statements of the Company for the Financial Year ended March 31, 2026, and the reports of the Board of Directors and Auditors’ thereon3 for0 against
- To declare a Final Dividend of Re. 1.00/- (50%) per Equity Shares of Rs.2/- for the Financial Year ended March 31, 2026.3 for0 against
To appoint a Director in place of Dr. Saloni Satish Wagh (DIN: 08491410) who retires by rotation in terms of Section 152 (6) of the Companies Act, 2013, and being eligible, offers herself for re-appointment.MoreLess
Against Angel One Mutual Fund
- Angel One Mutual FundGovernance and Transparency Concern: The Company’s remuneration practice is significantly skewed in favour of promoter Executive Directors including proposed Executive Directors, and no adequate rationale / justification has been provided for such disproportionate remuneration practice.
2 for1 against- To ratify the remuneration of Cost Auditors for FY 2025-263 for0 against
Mutual fund votes, meeting of 21 Aug 2026, 3 fund houses so far (houses' deadline to file 15 Oct 2026)
- Re-appointment of Mr. Balasaheb Sawant (DIN: 07743507) as Whole Time Director and Key Managerial Personnel of the Company for a term of three (3) consecutive years from May 26, 2026, to May 25, 2029
Against Angel One Mutual Fund, Quantum Mutual Fund
- Angel One Mutual FundCompliance & Transparency concern: The Company has not disclosed the remuneration drawn by the director during FY 2025-26 in the explanatory Statement forming part of the Notice. Hence, the proposed resolution is non-compliant under the Secretarial Standard on General Meetings (SS- 2). Further, the Board passed Circular resolution to re-appoint the proposed director as Whole Time Director and KMP, which also includes payment of revised remuneration. Since approval for appointment and remuneration of Whole Time Director shall be placed before the Board at its Meeting, and not passed through Circulation, the said Board’s approval is non-compliant with the Companies Act, 2013 and Secretarial Standard on Meetings of the Board of Directors (SS-1).
- Quantum Mutual FundWe do not have any concern on the profile and time commitments of Mr. Balasaheb Gulabrao Sawant. The proposed remuneration of Rs. 10.3 mn looks reasonable compared to the size and operations of the company. However, his overall attendance on a 3 Yrs average is 70% which is less than our internal threshold. Therefore, we do not favour the reappointment.
1 for2 against
6 earlier meetings
Mutual fund votes, meeting of 10 Apr 2026, 9 fund houses
- Appointment of Mr. Manish Panchal (DIN: 08431492) as Non-Executive Independent Director of the Company for a term of five (5) consecutive years from February 09, 2026, to February 08, 2031.
Against Angel One Mutual Fund, Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund
- Angel One Mutual FundCompliance and Transparency concern: The Company has not disclosed certain material details as required under Regulation 36(3) of the SEBI (LODR) Regulations, 2015 and Secretarial Standard–2 (SS-2) read with the Companies Act, 2013.
- Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual FundNo concerns identified on the merits, profile and time commitment of the proposed appointee. Compliance and Transparency concern: The Company has not disclosed certain material details as required under Regulation 36(3) of the SEBI (LODR) Regulations, 2015 and Secretarial Standard–2 (SS-2) read with the Companies Act, 2013.
5 for4 against - Appointment of Mr. Kothandaraman Hari (DIN: 08901674) as Non-Executive Independent Director of the Company for a term of five (5) consecutive years from February 09, 2026, to February 08, 2031.
Against Angel One Mutual Fund, Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund
- Angel One Mutual FundCompliance and Transparency concern: The Company has not disclosed certain material details as required under Regulation 36(3) of the SEBI (LODR) Regulations, 2015 and Secretarial Standard–2 (SS-2) read with the Companies Act, 2013.
- Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual FundNo concerns identified on the merits, profile and time commitment of the proposed appointee. Compliance and Transparency concern: The Company has not disclosed certain material details as required under Regulation 36(3) of the SEBI (LODR) Regulations, 2015 and Secretarial Standard–2 (SS-2) read with the Companies Act, 2013.
5 for4 against - Re-appointment of Dr. Neelam Arora (DIN: 01603068) as Non-Executive Independent Director of the Company for second term of five (5) consecutive years from March 25, 2026, to March 24, 2031.
Against Angel One Mutual Fund, Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund
- Angel One Mutual FundPrior approval of shareholders not obtained for re-appointment as an Independent Director. Compliance and Transparency concern: The Company has not disclosed certain material details as required under Regulation 36(3) of the SEBI (LODR) Regulations, 2015 and Secretarial Standard–2 (SS-2) read with the Companies Act, 2013.
- Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual FundNo concern on the merit of proposed appointee. Non-Compliance: Prior approval of shareholders not obtained for re-appointment as an ID. Compliance and Transparency concern: The Company has not disclosed certain material details as required under Regulation 36(3) of the SEBI (LODR) Regulations, 2015 and Secretarial Standard–2 (SS-2) read with the Companies Act, 2013.
5 for4 against
Mutual fund votes, meeting of 24 Sep 2025, 9 fund houses
- To receive, consider, approve and adopt the Audited Financial Statements of the Company for the Financial Year ended March 31, 2025 and the reports of the Board of Directors and Auditors’ thereon.9 for0 against
- To declare a Final Dividend of Re. 1.00/- (50%) per Equity Shares of Rs.2/- for the Financial Year ended March 31, 20259 for0 against
To appoint a Director in place of Mr. Balasaheb Sawant (DIN: 07743507) who retires by rotation in terms of Section 152 (6) of the Companies Act, 2013, and being eligible, offers himself for re-appointmentMoreLess
Against Mirae Asset Mutual Fund, WhiteOak Capital Mutual Fund
- Mirae Asset Mutual FundAs per advisory recommendation (Passive holding)
- WhiteOak Capital Mutual FundBalasaheb Sawant, 61, has over 29 years of experience in API production planning, material management, and process enhancement. He attended three out of five (60%) board meetings held in FY25. His attendance in FY23 and FY24 was also low, at 60% and 67% respectively. Given his low board meeting attendance, we are unable to support his reappointment to the board. We do not support the resolution.
7 for2 against- To ratify the remuneration of Cost Auditors for FY 2025-269 for0 against
- To appoint M/s DSM & Associates as Secretarial Auditors for a term of 5 consecutive years effective from FY 2025-26 to FY 2029-309 for0 against
Mutual fund votes, meeting of 23 Apr 2025, 8 fund houses
- Appointment of Dr. Ganapati Dadasaheb Yadav (DIN: 02235661) as Non Executive Independent Director of the Company8 for0 against
- 2 - Appointment of Dr. Sunil Subhash Bhagwat (DIN: 10178976) as Non Executive Independent Director of the Company8 for0 against
Mutual fund votes, meeting of 27 Sep 2024, 6 fund houses
- To receive, consider, approve and adopt the Audited Financial Statements of the Company for the financial year ended March 31, 2024 and the reports of the Board of Directors and Auditors thereon.6 for0 against
- To declare a Final Dividend on Equity Shares for the Financial Year ended March 31, 20246 for0 against
- To appoint a Director in place of Mrs. Smita Satish Wagh (DIN: 00833912) who retires by rotation and, being eligible, offers herself for re-appointment.6 for0 against
- To ratify the remuneration of Cost Auditors for the FY 2024-256 for0 against
- To reappoint Mrs. Smita Satish Wagh (DIN: 00833912) as Whole Time Director & Key Managerial Personnel of the Company6 for0 against
- To approve continuation of directorship of Mr. Dinesh Navnitlal Modi (DIN: 00004556) as a Non-Executive Independent Director beyond the age of 75 Years.
Against Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund
- Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual FundProposal compliant with law. No concern on the merits of the Director. Governance Concern: Combined position of AC & NRC Chairperson. Director is NRC Chair and the remuneration is skewed in favor of a Promoter director.
3 for3 against
Mutual fund votes, meeting of 28 Jul 2024, 4 fund houses
- Change in designation and appointment of Dr. Satish Waman Wagh (DIN: 01456982) as Whole Time Director and Key Managerial Personnel designated as Executive Chairman of the Company.
Against Groww Mutual Fund, Motilal Oswal Mutual Fund
- Groww Mutual Fund, Motilal Oswal Mutual FundCompliant with law. Governance concern: Excessive remuneration and Holding position of Executive Chairman.
2 for2 against - Change in designation and appointment of Dr. Saloni Satish Wagh (DIN: 08491410) as a Managing Director and Key Managerial Personnel of the Company.4 for0 against
- Change in designation and appointment of Ms. Shivani Satish Wagh (DIN: 08491420) as a Joint Managing Director and Key Managerial Personnel of the Company.4 for0 against
Mutual fund votes, meeting of 29 Sep 2023, 2 fund houses
- To receive, consider, approve and adopt the Audited Financial Statements of the Company for the financial year ended March 31, 2023 and the reports of the Board of Directors and Auditors thereon.2 for0 against
- To declare a Final Dividend on Equity Shares for the Financial Year ended March 31, 2023.2 for0 against
- To appoint a Director in place of Ms. Shivani Satish Wagh (DIN: 08491420) who retires by rotation and, being eligible, offers herself for re-appointment.2 for0 against
- To ratify the remuneration of Cost Auditors for the FY 2023-242 for0 against
Each fund house counted once, from its own disclosure; the reasons are its own words.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- Yes
- The chair is related to the managing director
- Yes
- The filing has a part on fines and penalties
- No
- The filing has a part on tax disputes
- No
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.